Yasmin Dahabreh
Research Subjects
Yasmin Dahabreh has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Hossam Salameh
Department of Medicine An‐Najah National University Nablus Palestine
2 shared publications Abdallah Ali Suleiman Al-Zayadneh
Faculty of Medicine, Yarmouk University, Irbid, Jordan
1 shared publicationAmal Mansor
Department of Medicine, An-Najah National University , Rafidia Street, Nablus P400
1 shared publicationAyman Haitham Khaled
Faculty of Medicine, An-Najah National University, Nablus, Palestine
1 shared publicationAzad Jehad Makableh
Faculty of Medicine, Yarmouk University, Irbid, Jordan
1 shared publication- Bara AbuBaha
Department of Medicine An‐Najah National University Nablus Palestine
1 shared publication
Latest Publications
- Open Access
- 24 January 2026
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2026 (1)
Unmasking Hirata: a mysterious case of Hypoglycemia triggered by immunologic storm
We report a rare case of Insulin Autoimmune Syndrome in a 35-year-old woman with prior autoimmune features who developed hypoglycemia after an allergic reaction. Diagnosis was confirmed by insulin autoantibodies. Immunosuppressive therapy yielded significant improvement. This case suggests a broader autoimmune process may underlie seemingly isolated IAS presentations.
- 24 January 2026
- Published by Oxford University Press (OUP) in Oxford Medical Case Reports
- Vol. 2026 (1)
Open AccessUnmasking Hirata: a mysterious case of Hypoglycemia triggered by immunologic storm
We report a rare case of Insulin Autoimmune Syndrome in a 35-year-old woman with prior autoimmune features who developed hypoglycemia after an allergic reaction. Diagnosis was confirmed by insulin autoantibodies. Immunosuppressive therapy yielded significant improvement. This case suggests a broader autoimmune process may underlie seemingly isolated IAS presentations.
- Open Access
- 18 January 2025
- Published by The Journal of Medicine, Law and Public Health (JMLPH) in The Journal of Medicine, Law & Public Health
- Vol. 5 (2) , 618-625
Laser-Induced Thermal Therapy in the Management of Low-Grade Gliomas: A Narrative Review
Background: Low-grade gliomas (LGGs) are slow-growing, World Health Organization Grade I and II tumors that can transform into more aggres-sive malignancies over time. This transformation pre- sents significant challenges in managing the burden of health care. Laser-induced thermal therapy (LITT) has emerged as a promising minimally invasive treat-ment option for LGGs, offering precise tumor ablation with minimal damage to surrounding tissues. Method: This narrative review synthesizes data from relevant studies on the evolution, clinical manifestations, mo-lecular characteristics, and emerging management strategies for LGGs, with a focus on the role of LITT. Results: LITT, a minimally invasive technique, offers targeted tumor ablation with the added benefit of disrupting the blood-brain barrier to enhance drug delivery. Studies have shown that LITT can effectively reduce tumor size and improve survival rates in patients with both primary and recurrent gliomas. However, challenges such as procedure-related complications, including motor deficits and cerebral edema, as well as the need for further research on long-term efficacy, remain. Conclusion: LITT represents a significant advancement in the treatment of LGGs, combining precision and minimal invasiveness. Future studies should focus on optimiz-ing protocols, integrating molecular and genetic in-sights, and assessing long-term outcomes to enhance therapeutic efficacy and patient quality of life.
- 18 January 2025
- Published by The Journal of Medicine, Law and Public Health (JMLPH) in The Journal of Medicine, Law & Public Health
- Vol. 5 (2) , 618-625
Open AccessLaser-Induced Thermal Therapy in the Management of Low-Grade Gliomas: A Narrative Review
Background: Low-grade gliomas (LGGs) are slow-growing, World Health Organization Grade I and II tumors that can transform into more aggres-sive malignancies over time. This transformation pre- sents significant challenges in managing the burden of health care. Laser-induced thermal therapy (LITT) has emerged as a promising minimally invasive treat-ment option for LGGs, offering precise tumor ablation with minimal damage to surrounding tissues. Method: This narrative review synthesizes data from relevant studies on the evolution, clinical manifestations, mo-lecular characteristics, and emerging management strategies for LGGs, with a focus on the role of LITT. Results: LITT, a minimally invasive technique, offers targeted tumor ablation with the added benefit of disrupting the blood-brain barrier to enhance drug delivery. Studies have shown that LITT can effectively reduce tumor size and improve survival rates in patients with both primary and recurrent gliomas. However, challenges such as procedure-related complications, including motor deficits and cerebral edema, as well as the need for further research on long-term efficacy, remain. Conclusion: LITT represents a significant advancement in the treatment of LGGs, combining precision and minimal invasiveness. Future studies should focus on optimiz-ing protocols, integrating molecular and genetic in-sights, and assessing long-term outcomes to enhance therapeutic efficacy and patient quality of life.